Anika Therapeutics, Inc. (ANIK) Reports Q2 Earnings of $0.17, Revenues Increase Y/Y
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.00 +0.77%
Revenue Growth %: +5.5%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +5.5%
Financial Fact:
Interest income (expense), net: 93K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.17, versus $0.08 reported last year. Revenue for the quarter came in at $16.1 million, versus $13.7 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Piper Sandler Reiterates Overweight Rating on Block Inc. (XYZ)
- Surgery Partners sells Idaho Falls facilities to Intermountain Health for $797M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
